Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking

Mark E. Mummert, Mansour Mohamadzadeh, Diana I. Mummert, Norikatsu Mizumoto, Akira Takashima

Resultado de la investigación: Articlerevisión exhaustiva

99 Citas (Scopus)


Hyaluronan (HA), a high molecular weight glycosaminoglycan, is expressed abundantly in the extracellular matrix and on cell surfaces. Although HA is known to bind many adhesion molecules, little information has been available with respect to its direct physiological role. In this study, we developed a novel 12-mer (GAHWQFNALTVR) peptide inhibitor of HA, termed 'Pep-1,' by using phage display technology. Pep-1 showed specific binding to soluble, immobilized, and cell-associated forms of HA, and it inhibited leukocyte adhesion to HA substrates almost completely. Systemic, local, or topical administration of Pep-1 inhibited the expression of contact hypersensitivity responses in mice by blocking skin-directed homing of inflammatory leukocytes. Pep-1 also inhibited the sensitization phase by blocking hapten-triggered migration of Langerhans cells from the epidermis. These observations document that HA plays an essential role in 'two-way' trafficking of leukocytes to and from an inflamed tissue, and thus provide technical and conceptual bases for testing the potential efficacy of HA inhibitors (e.g., Pep-1) for inflammatory disorders.

Idioma originalEnglish (US)
Páginas (desde-hasta)769-779
Número de páginas11
PublicaciónJournal of Experimental Medicine
EstadoPublished - 2000
Publicado de forma externa

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Profundice en los temas de investigación de 'Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking'. En conjunto forman una huella única.

Citar esto